Sources

  1. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous deficient and evaporative dry eye in a clinic-based patient population. Cornea. 2012 May;31(5):472-8.
  2. Korb DR, Henriquez AS. Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc. 1980 Mar;51(30):243-51.
  3. Han KE, et al. Evaluation of dry eye and meibomian gland dysfunction after cataract surgery. Am J Ophthalmol. 2014 Jun;157(6):1144-1150.
  4. Blackie C, Carlson AN, Korb DR.Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review.  Current Opinion in Ophthalmology. 2015 Jul;26(4):306-13.
  5. Shimazaki J. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995 Oct; 113(10):1266-70.
  6. Portello JK, Rosenfield M, Chu CA. Blink rate, incomplete blinks and computer vision syndrome. Optom Vis Sci. 2013 May;90(5):482-7.
  7. Erginturk Acar D, et al. The effects of smoking on dry eye paramters in healthy women. Cutan Ocul Toxicol. 2016 Jan 28:1-4.
  8. Yang WJ, et al. Risk factors for dry eye syndrome: aretrospective case-control study. Optom Vis Sci. 2015 Sep;92(9):e199-205.
  9. Ghosh S, O’Hare F, et al. Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication. Clin Experiment Ophthalmol. 2012 Sep-Oct;40(7):675-81.
  10. Wolkoff P. Ocular discomfort by environmental and personal risk factors altering the precorneal tear film. Toxicol Lett. 2010 Dec 15;199(3):203-12.
  11. Lane SS, et al. A New System, the LipiFlow, for the Treatment of Meibomian Gland Dysfunction (MGD). Cornea 1/4/12.
  12. Schaumberg DA, Nichols JJ, Papas EB, et al.  The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on the Epidemiology of, and Associated Risk Factors for, MGD.  Invest Ophthalmol Vis Sci. 2011;52:1994–2005.